Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a vaccine therapy in combination with sargramostim (GM-CSF) for malignant glioma, including several glioma subtypes; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Brain Neoplasm
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Mixed Glioma

Drugs mentioned

• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma | Phase 1 | Status: COMPLETED